Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 302.25M P/E - EPS this Y -3.60% Ern Qtrly Grth -
Income -124.08M Forward P/E -2.25 EPS next Y -4.00% 50D Avg Chg -26.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 16.00%
Dividend N/A Price/Book 1.40 EPS next 5Y - 52W High Chg -44.00%
Recommedations 1.90 Quick Ratio 4.60 Shares Outstanding 78.52M 52W Low Chg 176.00%
Insider Own 1.12% ROA -36.49% Shares Float 42.74M Beta 2.61
Inst Own 77.57% ROE -64.83% Shares Shorted/Prior 3.37M/2.55M Price 4.52
Gross Margin - Profit Margin - Avg. Volume 577,762 Target Price 19.43
Oper. Margin - Earnings Date - Volume 481,870 Change -2.80%
About Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Tenaya Therapeutics, Inc. News
04:00 PM Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
04/14/24 Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company
03/26/24 20 Countries with the Highest Heart Disease Deaths Per Capita
03/20/24 Tenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial Results
03/18/24 Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
03/18/24 Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
02/29/24 14 Stocks With Heavy Insider Buying In 2024
02/27/24 Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
02/26/24 Should You Buy Tenaya Therapeutics, Inc. (TNYA) After Golden Cross?
02/26/24 Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
02/09/24 Wall Street Analysts Think Tenaya Therapeutics, Inc. (TNYA) Could Surge 273.1%: Read This Before Placing a Bet
02/08/24 Tenaya Therapeutics Announces Pricing of Underwritten Offering
01/26/24 Tenaya Therapeutics, Inc. (TNYA) Upgraded to Strong Buy: Here's Why
01/03/24 Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
11/21/23 Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference
11/08/23 Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
11/06/23 Institutional investors have a lot riding on Tenaya Therapeutics, Inc. (NASDAQ:TNYA) with 38% ownership
10/26/23 Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
10/10/23 We Think Tenaya Therapeutics (NASDAQ:TNYA) Needs To Drive Business Growth Carefully
10/09/23 Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting
TNYA Chatroom

User Image Stock_Titan Posted - 6 hours ago

$TNYA Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting https://www.stocktitan.net/news/TNYA/tenaya-therapeutics-to-highlight-growing-capabilities-in-capsid-6138k9b0w01a.html

User Image CristoferAtlantis Posted - 04/29/24

$TNYA I'm getting out at $5

User Image John___wick44 Posted - 04/26/24

$TNYA market up a gazillion and this is going red. why is that? rates are going higher for a long time. buy back at 1.50

User Image John___wick44 Posted - 04/25/24

$TNYA week early. stock is kaput. ten year going over 5 stock easily back to 2

User Image mikalele1 Posted - 04/22/24

$TNYA Sorry not to be here for a long time. No news = no comments. I have just bought some shares IN THE END, but I don't have the temperance to look at the ups and downs every day... So good luck.

User Image John___wick44 Posted - 04/19/24

$TNYA same pattern as last year to a tee. hit 7 and has dropped sonce then with very few upticks. by end of summer look for 2’s possibly 1’s again. zero reason for this to go up

User Image John___wick44 Posted - 04/18/24

$TNYA could get to under 4 today. going right back to lows. higher rates, no news, questionable data. bye bye

User Image John___wick44 Posted - 04/17/24

$TNYA under 4 by weeks end. trek towards 2

User Image John_D_Stockefeller Posted - 04/16/24

$TNYA sick of these off-hours head fakes.

User Image John___wick44 Posted - 04/15/24

$TNYA 10 year going to 5.50 by year end or early next year and this will be back under two by then. keep powder dry.

User Image JayMedina Posted - 04/11/24

$TNYA glad it’s been maintained at these levels.

User Image mikalele1 Posted - 1 month ago

$TNYA The next thing John_D_Stockefeller will say is that the news about Verve Therapeutics are good for Tenaya... Lol

User Image 7BillyBiggs Posted - 1 month ago

$XBI $ALT $CDIO $AKBA $MDGL$ OCGN $TNYA Theres a great bargain sale happening today in the BIO sector get your shares while they're on sale!

User Image John___wick44 Posted - 1 month ago

$TNYA higher rates for longer is going to sink this stock and all micro cap biotech

User Image svertical1 Posted - 1 month ago

$CRSP $NTLA $EDIT $TNYA No shortage of lucrative targets. https://www.theepochtimes.com/world/researchers-uncover-gene-mutation-responsible-for-psoriasis-5615014?utm_source=Health&src_src=Health&utm_campaign=health-2024-04-01&src_cmp=health-2024-04-01&utm_medium=email&est=AAAAAAAAAAAAAAAAcqwkeQAJx%2BHJ%2BKdAsGBNlNxY6i9c3nPV66Wazw3Fvw%3D%3D

User Image Exploreatwill Posted - 03/27/24

$TNYA well that was fast! Looking for two things, as I mentioned earlier a close above 618 fib which should $5ish and we have the 50SMA which the bulls have now made a target with this move in the last hour. closing the day above 5.11 would print a clear sign that bulls are ready to get back in the driver seat .

User Image Exploreatwill Posted - 03/27/24

$TNYA so we had a 50% retracement and held and now trying to break 618, could go either way, but a support from .5 and a consolidation around the 618 typical favors the bulls.. daily close above $5 would be the litmus test.

User Image John_D_Stockefeller Posted - 03/22/24

$TNYA John Wick 44, in November, when this was in the $1s, was calling for a r/s, and pennies in December. Ran to $7s.

User Image John_D_Stockefeller Posted - 03/22/24

$TNYA John Wick44 was bashing in the $1s, in November. Called for reverse split, etc., bash, bash, then it went straight up to @$7. That guy……lol.

User Image John___wick44 Posted - 03/22/24

$TNYA another red day people. market still has not corrected. they are toast

User Image mikalele1 Posted - 03/22/24

$TNYA CKD-510 (the korean HDAC6 inhibitor) is potential treatment for Charcot-Marie-Tooth disease, but also has potential against atrial fibrillation and a potential treatment of heart failure with preserved ejection fraction. But Novartis knows nothing...On a train trip to my destination, lol

User Image John___wick44 Posted - 03/22/24

$TNYA buy at 2. market will correct and this will get crushed. no news for 6 months and not even big news. support broken.

User Image Thestocktraderhubzee Posted - 03/22/24

WATCHLIST MAR 22 2024. $MU B of A Securities Maintains Buy on Micron Technology, Raises Price Target to $120 $ZTO HSBC Maintains Buy on ZTO Express (Cayman), Lowers Price Target to $30 $CHWY B of A Securities Maintains Underperform on Chewy, Lowers Price Target to $16.5 $TNYA Chardan Capital Reiterates Buy on Tenaya Therapeutics, Maintains $20 Price Target $SRE Morgan Stanley Maintains Equal-Weight on Sempra, Raises Price Target to $75

User Image AmbushPredator Posted - 03/21/24

$TNYA looking to buy, but it looks like you’ll think this is heading south?

User Image mikalele1 Posted - 03/21/24

$TNYA I will try again: Why Novartis choose the korean hdac6 inhibitor and not the Tenaya one? Anyone knows more than Novartis in this matter? Greetings from Tenayo. Many criticism, short detected, whatever... But no answers.

User Image Thestocktraderhubzee Posted - 03/21/24

$TNYA Chardan Capital Reiterates Buy on Tenaya Therapeutics, Maintains $20 Price Target

User Image John___wick44 Posted - 03/21/24

$TNYA stockefeller u will be thanking me later. rinse and repeat. i will be buying back at 2 or under for the next pump

User Image John_D_Stockefeller Posted - 03/21/24

$TNYA John Wick44 is desperate.

User Image John___wick44 Posted - 03/21/24

$TNYA $2 stock again. market will correct and this stock has no news for 6 months . tn301 is aflop. no good

User Image John___wick44 Posted - 03/21/24

$TNYA hope you all trimmed thise long positions. this trend down has only begun.

Analyst Ratings
Chardan Capital Buy Mar 21, 24
Canaccord Genuity Buy Mar 20, 24
HC Wainwright & Co. Buy Mar 19, 24
Leerink Partners Outperform Nov 30, 23
HC Wainwright & Co. Buy Oct 9, 23
Chardan Capital Buy Aug 14, 23
Canaccord Genuity Buy Aug 11, 23
Morgan Stanley Overweight Aug 10, 23
HC Wainwright & Co. Buy Aug 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hoey Timothy Chief Scientific Off.. Chief Scientific Officer Aug 29 Sell 4.26 7,243 30,855 247,396 08/29/23
Hoey Timothy Chief Scientific Off.. Chief Scientific Officer Aug 16 Sell 3.81 4,007 15,267 254,639 08/18/23
Tingley Whittemore Chief Medical Office.. Chief Medical Officer Aug 16 Sell 3.81 5,563 21,195 76,437 08/18/23
PATTERSON LEONE D Chief Fin. and Bus... Chief Fin. and Bus. Officer Aug 16 Sell 3.81 4,452 16,962 64,542 08/18/23
Ali Faraz Chief Executive Offi.. Chief Executive Officer Aug 16 Sell 3.81 5,563 21,195 119,437 08/18/23
GOEDDEL DAVID V Director Director Jan 17 Buy 2.51 185,151 464,729 9,800,535 01/19/23
Srivastava Deepak Director Director Nov 21 Buy 2.60 230,769 599,999 372,435 12/09/22
Srivastava Deepak Director Director Nov 21 Buy 2.60 230,769 599,999 372,435 12/09/22
Casdin Eli Director Director Nov 17 Buy 2.60 2,492,042 6,479,309 6,078,860 11/25/22
Hoey Timothy Chief Scientific Off.. Chief Scientific Officer Apr 26 Sell 10.13 1,353 13,706 198,646 04/28/22